Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP vs TAP block in laparoscopic bariatric surgery
NCT04417179Completed
- Sponsor
- Cairo University
- Start
- Aug 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in postoperative pain, sponsored by Cairo University. Primary endpoint: Efficacy of block at 24 hours. Started Aug 2020; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04417179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04417179.